Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Venture Capital

Proclara Biosciences Lands $47M Series E

by posted 2years ago 4535 views
Proclara's $47 million Series E financing was led by existing investors, including private investors and Merieux Developpement. The financing will support further clinical development of NPT088, as well as the preclinical advancement of additional molecules toward the clinic. With completion of this financing, Proclara has raised more than $110 million to date.